Evaluation of Adrenal Suppression of a Lipid Enhanced, Topical Emollient Cream Formulation of Hydrocortisone Butyrate 0.1% in Treating Children with Atopic Dermatitis-Reference-Cited by-同舟云学术

Evaluation of Adrenal Suppression of a Lipid Enhanced, Topical Emollient Cream Formulation of Hydrocortisone Butyrate 0.1% in Treating Children with Atopic Dermatitis

Published:2007-02-02 Issue:1 Volume:24 Page:81-84
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:

Author:

Eichenfield Lawrence,Ellis Charles N.,Fivenson David,Hebert Adelaide A.,Dromgoole Syd,Piacquadio Daniel

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1525-1470.2007.00342.x/fullpdf

Reference9 articles.

1. Atopic dermatitis: a genetic-epidemiological study in a population-based twin sample;Schultz-Larsen;J Am Acad Dermatol,1986

2. The prevalence of atopic dermatitis in Oregon schoolchildren;Laughter;J Am Acad Dermatol,2000

3. Consensus conference on pediatric atopic dermatitis;Eichenfield;J Am Acad Dermatol,2003

4. http://www.aadassociation.org/Guidelines/atopic.html

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosing Beyond Bias: Differentiating Topical Steroid Withdrawal Syndrome From irAE-Induced Adrenal Insufficiency;Cureus;2023-12-10

2. Safety of topical medications in the management of paediatric atopic dermatitis: An updated systematic review;British Journal of Clinical Pharmacology;2023-05-09

3. Topical steroid withdrawal syndrome: Should we worry?;Annals of Allergy, Asthma & Immunology;2023-01

4. A low level of health literacy is a predictor of corticophobia in atopic dermatitis;Anais Brasileiros de Dermatologia;2022-11

5. Safety of topical corticosteroids in atopic eczema: an umbrella review;BMJ Open;2021-07